Search results

Narrow your search

Result types

Showing 921 - 930 of 1741 for "Makes & Partners" with applied filters

News & Analysis

Civil Court Lacks Jurisdiction to Determine Validity of Registered Plant Variety

03 August 2023 by LexOrbis - India : Manisha Singh (Partner) & Neha Ruhela (Senior Associate)

In India, the protection of plant varieties is outside the purview of the patent system.

News & Analysis

Comparative Advertisement under the Trademark Regime

02 August 2023 by Rahul Chaudhry & Partners - India: Aakriti Singh, Associate

This article analyses the concept of comparative advertising within the domain of the Trademark regime, studying the various components involved, including the statutory laws and judicial pronouncements in India.

News & Analysis

Strengthening Regulation of Unfair Trading through Amendment of FISCMA

24 July 2023 by Lee & Ko - South Korea

A proposal for partial amendment (Amendment) to the Financial Investment Services and Capital Markets Act (FISCMA) for the purpose of strengthening the regulation of unfair trading passed the plenary session of the National Assembly of Korea on June 30, 2023 and was promulgated on July 18, 2023.

News & Analysis

HKD-RMB Dual Counter Model in Hong Kong’s stock market

17 July 2023 by LC Lawyers - Rossana Chu, Managing Partner

The Hong Kong Dollar (HKD)-Renminbi (RMB) Dual Counter Model was launched in the Hong Kong stock market on 19 June 2023. The first batch covers 24 companies which already have their shares listed on the Main Board of the Hong Kong Stock Exchange and traded in HKD.

News & Analysis

IndusLaw bolsters it's infrastructure & energy practice

17 July 2023 by IndusLaw

INDUSLAW is pleased to announce the addition of Shashwat Kumar, who has joined our Delhi & NCR office in the Infrastructure & Energy practice.

News & Analysis

mRNA Vaccines: A Breakthrough Technology

11 July 2023 by LexOrbis - India: Manisha Singh (Partner) & Vaneet Kaur (Senior Associate)

RNA molecules have been utilized as therapeutic and research tools for more than two decades, with the usage ranging from in vitro transcribed (IVT) mRNA, small interference RNA (siRNA), RNA aptamers, riboswitches, and antisense RNA to the recently developed mRNA vaccines.

News & Analysis

Note on Nokia v. Oppo (3rd July 2023)

03 July 2023 by Anand and Anand - India

For several years, patent owners navigated the SEP landscape in India, unsure of their destination (injunction, damages, FRAND verdicts), and wondering whether their opponents (implementers of SEPs) could be made to deposit security, to protect the SEP owners’ interests.

News & Analysis

Can Liquidated Damages and Penalty Clauses Survive under Korean Law?

03 July 2023 by Jipyong - South Korea

Foreign contractors and subcontractors doing business with Korean companies are often puzzled by how Korean courts deal with liquidated damages and penalty clauses in contracts.

News & Analysis

Anand and Anand ‘highly commended’ for its Luxury Law Practice

27 June 2023 by Anand and Anand - India

The firm has won Luxury law Firm Award twice earlier; only Indian firm to be so recognised

News & Analysis

Trademark protection of signature poses and voices of celebrities in India: An uncharted territory

08 June 2023 by Rahul Chaudhry & Partners - India: Sakshi Mathur, Associate

Personality rights, commonly known as ‘right of publicity,’ guarantees an individual right in one’s personal attributes such as appearance, signature, voice, silhouette, face, features, gestures, expressions, mannerisms etc, paving way for an individual to use and commercialise one’s identity.